Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary mediastinal seminoma.

S E Bush, A Martinez, M A Bagshaw

    Cancer
    |October 15, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Primary mediastinal seminoma, a rare cancer, shows a 69% ten-year survival rate with radiotherapy. Doses over 4700 rads prevent relapse, establishing optimal treatment guidelines.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A novel entorhinal projection to the rat dentate gyrus: direct innervation of proximal dendrites and cell bodies of granule cells and GABAergic neurons.

    The Journal of neuroscience : the official journal of the Society for Neuroscience·1996
    Same author

    Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.

    Gastroenterology·1996
    Same author

    Mutational analysis and secondary structure model of the RNP1-like sequence motif of transcription termination factor Rho.

    Journal of molecular biology·1996
    Same author

    Residues in the RNP1-like sequence motif of Rho protein are involved in RNA-binding affinity and discrimination.

    Journal of molecular biology·1996
    Same author

    Effects of continuous low-dose-rate brachytherapy on the rectum of the rat.

    Radiation research·1996
    Same author

    Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.

    The American journal of tropical medicine and hygiene·1996
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Area of Science:

    • Oncology
    • Radiation Oncology
    • Medical Physics

    Background:

    • Primary mediastinal seminoma is a rare germ cell neoplasm.
    • It is histologically identical to testicular seminoma.
    • Definitive megavoltage radiotherapy is a treatment option.

    Observation:

    • Thirteen patients with primary mediastinal seminoma were treated with megavoltage radiotherapy between 1961 and 1976.
    • Radiation doses ranged from 2500 to 6000 rads.
    • Follow-up included actuarial survival and relapse-free survival rates.

    Findings:

    • Ten-year actuarial survival rate was 69%, with a 54% relapse-free survival.
    • No local or systemic relapse occurred in patients receiving over 4700 rads.
    • Relapse patterns were analyzed to inform diagnostic evaluation.

    Related Experiment Videos

    Implications:

    • A primary megavoltage irradiation dose of 4500 to 5000 rads over five to six weeks is recommended.
    • This dose range appears to be appropriate for definitive treatment.
    • Understanding relapse patterns aids in refining patient follow-up strategies.